Epigenetics in the pathogenesis of systemic lupus erythematosus

Current Opinion in Rheumatology

Volumn 25, Issue 5, 2013, Pages 569-575

  Altorok, Nezam ^a   Sawalha, Amr H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

DNA methylation; epigenetics; histone modification; lupus; microRNA

Indexed keywords

DNA METHYLTRANSFERASE; INTERLEUKIN 2; MICRORNA; PHOSPHOPROTEIN PHOSPHATASE 2A;

CD4+ T LYMPHOCYTE; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE EXPRESSION REGULATION; GENE INTERACTION; HISTONE MODIFICATION; HUMAN; MONOZYGOTIC TWINS; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; TWIN STUDIES AS TOPIC;

EID: 84881544609     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328364206f     Document Type: Review

References (63)

1. Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 2011; 40:42-49; Epub 2010/01/12.
2. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007; 3:521-527; Epub 2007/09/01.
3. Ballestar E, Esteller M, Richardson BC. The epigenetic face of systemic lupus erythematosus. J Immunol 2006; 176:7143-7147; Epub 2006/06/06.
4. Richardson B. Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self reactivity in antigen-specific T4+ cells. Hum Immunol 1986; 17:456-470.
5. Deng C, Lu Q, Zhang Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 2003; 48:746-756; Epub 2003/03/13.
6. Deng C, Kaplan MJ, Yang J, et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001; 44:397-407; Epub 2001/03/07.
7. Richardson B, Scheinbart L, Strahler J, et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33:1665-1673; Epub 1990/11/01.
8. Quddus J, Johnson KJ, Gavalchin J, et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92:38-53; Epub 1993/07/01.
9. Lu Q, Kaplan M, Ray D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282-1291; Epub 2002/07/13.
10. Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupusinducing drugs. J Immunol 2005; 174:6212-6219; Epub 2005/05/10.
11. Lu Q, Wu A, Tesmer L, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007; 179:6352-6358; Epub 2007/10/20.
12. Kaplan MJ, Lu Q, Wu A, et al. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172:3652-3661; Epub 2004/03/09.
13. Lu Q, Wu A, Ray D, et al. DNA methylation and chromatin structure regulate T cell perforin gene expression. J Immunol 2003; 170:5124-5132; Epub 2003/05/08.
14. Liu Y, Kuick R, Hanash S, Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009; 130:213-224; Epub 2008/10/24.
15. Richardson BC. Epigenetics and autoimmunity. Overview. Autoimmunity 2008; 41:243-244; Epub 2008/04/25.
16. Kammer GM, Tsokos GC. Abnormal T lymphocyte signal transduction in systemic lupus erythematosus. Curr Dir Autoimmun 2002; 5:131-150; Epub 2002/02/06.
17. Cedeno S, Cifarelli DF, Blasini AM, et al. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunol 2003; 106:41-49; Epub 2003/02/14.
18. Sawalha AH, Jeffries M, Webb R, et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylationsensitive genes similar to lupus patients. Genes Immun 2008; 9:368-378; Epub 2008/06/05.
19. Tada Y, Nagasawa K, Yamauchi Y, et al. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60:220-231; Epub 1991/08/01.
20. Miyamoto A, Nakayama K, Imaki H, et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002; 416:865-869; Epub 2002/04/27.
21. Gorelik G, Fang JY, Wu A, et al. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazineinduced lupus. J Immunol 2007; 179:5553-5563; Epub 2007/10/04.
22. Sawalha AH, Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur J Immunol 2007; 37:1407-1413; Epub 2007/04/13.
23. Scofield RH, Bruner GR, Namjou B, et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008; 58:2511-2517; Epub 2008/08/01.
24. Sawalha AH, Webb R, Han S, et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PloS One 2008; 3:e1727; Epub 2008/ 03/06.
25. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19:187-191; Epub 1998/06/10.
26. Kimura H, Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem 2003; 278:4806-4812; Epub 2002/12/11.
27. Chahrour M, Jung SY, Shaw C, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320:1224-1229; Epub 2008/05/31.
28. Webb R, Wren JD, Jeffries M, et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum 2009; 60:1076-1084; Epub 2009/04/01.
29. Koelsch KA, Webb R, Jeffries M, et al. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun 2013; Epub 2013/02/23.
30. Strickland FM, Hewagama A, Lu Q, et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J Autoimmun 2012; 38:J135-J143; Epub 2011/12/07.
31. Sawalha AH, Wang L, Nadig A, et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J Autoimmun 2012; 38:J216-J222; Epub 2012/02/07.
32. Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35:311-318; Epub 1992/03/01.
33. Javierre BM, Fernandez AF, Richter J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010; 20:170-179; Epub 2009/12/24.
34. Zhou Y, Qiu X, Luo Y, et al. Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells. Lupus 2011; 20:1365-1371; Epub 2011/08/26.
35. Li Y, Zhao M, Yin H, et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum 2010; 62:1438-1447; Epub 2010/02/05.
36. Jeffries MA, Dozmorov M, Tang Y, et al. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011; 6:593-601; Epub 2011/03/26.
37. Zhao M, Wu X, Zhang Q, et al. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res Ther 2010; 12:R227; Epub 2011/01/05.
38. Xu J, Zhang G, Cheng Y, et al. Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Lupus 2011; 20:678-689; Epub 2011/03/09.
39. Sunahori K, Juang YT, Kyttaris VC, Tsokos GC. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J Immunol 2011; 186:4508-4517; Epub 2011/02/25.
40. Zhang Q, Long H, Liao J, et al. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus. J Autoimmun 2011; 37:180-189; Epub 2011/10/22.
41. Zhang Z, Song L, Maurer K, et al. Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun 2010; 11:124-133; Epub 2009/08/28.
42. Zhao S, Wang Y, Liang Y, et al. MicroRNA-126 regulates DNA methylation in CD4(+) T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2010; Epub 2010/12/18.
43. Pan W, Zhu S, Yuan M, et al.MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010; 184:6773-6781; Epub 2010/05/21.
44. Divekar AA, Dubey S, Gangalum PR, Singh RR. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol 2011; 186:924-930; Epub 2010/12/15.
45. Dai R, Zhang Y, Khan D, et al. Identification of a common lupus diseaseassociated microRNA expression pattern in three different murine models of lupus. PloS One 2010; 5:e14302; Epub 2010/12/21.
46. Rouas R, Fayyad-Kazan H, El Zein N, et al. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 2009; 39:1608-1618; Epub 2009/05/02.
47. Lu MC, Lai NS, Chen HC, et al. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol 2013; 171:91-99; Epub 2012/12/04.
48. Zhao X, Tang Y, Qu B, et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 2010; 62:3425-3435; Epub 2010/ 07/01.
49. Ding S, Liang Y, Zhao M, et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum 2012; 64:2953-2963; Epub 2012/05/03.
50. Tang Y, Luo X, Cui H, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60:1065-1075; Epub 2009/ 04/01.
51. Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 2005; 115:3193-3204; Epub 2005/10/15.
52. Wadzinski BE, Wheat WH, Jaspers S, et al. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 1993; 13:2822-2834; Epub 1993/05/01.
53. Crispin JC, Apostolidis SA, Finnell MI, Tsokos GC. Induction of PP2A Bbeta, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus. Proc Natl Acad Sci U S A 2011; 108:12443-12448; Epub 2011/07/13.
54. Hellstrand K, Hermodsson S. Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors. Cell Immunol 1990; 127:199-214; Epub 1990/04/15.
55. Eugen-Olsen J, Afzelius P, Andresen L, et al. Serotonin modulates immune function in T cells from HIV-seropositive subjects. Clin Immunol Immunopathol 1997; 84:115-121; Epub 1997/08/01.
56. Parbtani A, Frampton G, Yewdall V, et al. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus. Clin Nephrol 1980; 14:164-172; Epub 1980/10/01.
57. Zhang F, Meng G, Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol 2008; 9:1297-1306; Epub 2008/10/14.
58. Kondo Y, Shen L, Cheng AS, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40:741-750; Epub 2008/05/20.
59. Schulze-Luehrmann J, Santner-Nanan B, Jha MK, et al. Hematopoietic progenitor kinase 1 supports apoptosis of T lymphocytes. Blood 2002; 100:954-960; Epub 2002/07/20.
60. Shui JW, Boomer JS, Han J, et al. Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses. Nat Immunol 2007; 8:84-91; Epub 2006/11/23.
61. Liang D, Shen N. MicroRNA involvement in lupus: the beginning of a new tale. Curr Opin Rheumatol 2012; 24:489-498; Epub 2012/06/27.
62. Zhao S, Wang Y, Liang Y, et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011; 63:1376-1386; Epub 2011/05/04.
63. Stagakis E, Bertsias G, Verginis P, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 2011; 70:1496-1506; Epub 2011/05/24.